Skip to Content
MilliporeSigma
  • Clearance of nasal Staphylococcus aureus colonization with triple antibiotic ointment.

Clearance of nasal Staphylococcus aureus colonization with triple antibiotic ointment.

Journal of drugs in dermatology : JDD (2013-02-05)
Elizabeth M Grossman, Shivani Nanda, Jennifer R S Gordon, Meghan Dubina, Alfred W Rademaker, Dennis P West, Peter A Lio
ABSTRACT

The prevalence of Staphylococcus aureus colonization of healthcare workers is reported at 30%, with colonization rates for methicillin-resistant S aureus (MRSA) reported between 2.0% and 8.5% among industrialized nations. The anterior nares are the most frequent colonization site. Mupirocin is the standard of care for nasal S aureus decolonization, with decolonization rates as high as 90%. Staphyloccocal resistance to mupirocin has been described, requiring additional management strategies. In certain situations, triple antibiotic ointment (TAO) may be a suitable alternative for elimination of nasal S aureus colonization. Adult healthcare workers within an academic-centered hospital (n=216) were screened via nasal swab with culture for S aureus colonization. Forty-!ve subjects (20.8%) screened positive for S aureus; of these subjects, 3 (1.4%) were positive for MRSA. Of the 45 subjects with positive cultures, 30 completed 5 days of twice-daily intranasal TAO application. One week after treatment, all 30 subjects were reswabbed; 16 (53.3%) showed evidence of decolonization on repeat culture. The rate of S aureus colonization of healthcare workers in our study is lower than published rates in industrialized nations. Intranasal application of TAO may be a viable option for eradication of nasal colonization by methicillin-susceptible S aureus in environments where mupirocin-resistant bacterial strains become more prevalent.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Bacitracin, from Bacillus licheniformis, ≥65 IU/mg
Supelco
Neomycin trisulfate salt hydrate, VETRANAL®, analytical standard
Sigma-Aldrich
Neomycin trisulfate salt hydrate, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Neomycin trisulfate salt hydrate, meets USP testing specifications, powder
Sigma-Aldrich
Bacitracin, from Bacillus licheniformis, ≥65 IU/mg
Sigma-Aldrich
Polymyxin B sulfate salt
Sigma-Aldrich
Polymyxin B sulfate salt, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Bacitracin zinc salt, from Bacillus licheniformis, ~70,000 U/g
Sigma-Aldrich
Neomycin trisulfate salt hydrate, suitable for plant cell culture
Sigma-Aldrich
Neomycin trisulfate salt hydrate, powder
Supelco
Polymyxin B solution, 1 mg/mL in H2O, analytical standard
Sigma-Aldrich
Polymyxin B solution, 20 mg/mL in H2O
Neomycin sulphate, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Polymyxin B sulfate, meets USP testing specifications
Polymyxin B sulfate, European Pharmacopoeia (EP) Reference Standard